AzTrials
AzTrials

StressNCT07804927

STRess Assessment of INterventional Cardiology Fellows and Attendings

An observational study of Stress, run by Minneapolis Heart Institute Foundation at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Interventional cardiology (IC) fellows and attendings experience high levels of stress. In a recent study, IC fellowship was considered very stressful by 22%, somewhat stressful by 62%, and not stressful by 16%(1). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stress
How many people
15 participants
Where
1 siteUnited States
Study dates
4 Oct 2023to 4 Oct 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The target study population is all interventional cardiology attendings and fellows at Minneapolis Heart Institute.

Who may be able to join

  • Interventional Cardiology fellow or attending.
  • Age 18 years or older.
  • Willing and able to provide informed consent.
  • Access to smartphone (Apple or Android platform).
  • Willing and able to wear the wearable devices.

Who cannot join

  • 1- Any health condition that in the opinion of the investigator would preclude individual's participation in the study such as conditions that would preclude them from wearing the study wearables and participating to provide wearable data.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Minneapolis Heart Institute Foundation

    Minneapolis, Minnesota, 55407

    Bavana V Rangan, BDS, MPH, 817-821-9945, bavana.rangan@allina.com

    Recruiting

Other trials in United States

About this study

Interventional cardiology (IC) fellows and attendings experience high levels of stress. In a recent study, IC fellowship was considered very stressful by 22%, somewhat stressful by 62%, and not stressful by 16%(1). In a different study, 29% of the IC fellows considered leaving their job during the past year, while more than a quarter (29%) felt overwhelmed ≥3x/week(2). Moreover, the same study reports that burnout affects 69% of the interventional cardiologists. In addition, in the Medscape Cardiologist Lifestyle, Happiness \& Burnout Report 2023, 43% of the cardiologists in general reported being burned out and 23% were depressed(3). However, it remains unknown whether they deal with increased stress before, during, and after a procedure, if their stress decreases (and if so, how much) with experience, and how they recover after a procedure. The present study will study the stress levels of IC fellows and attendings using various subjective metrics and wearable devices.

Conditions
Stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart Rate Variability (HRV)

    Heart Rate Variability (HRV) as assessed by the wearable devices

    Measured: From enrollment to end of study period at 14 days

Secondary outcomes (10)
  1. Stress

    Subjective stress assessed by the STAI-short version at baseline, before and after a procedure. Higher scores on the STAI indicate greater anxiety

    Measured: Baseline and at the end of study period at 14 days

  2. Procedural characteristics

    Procedural characteristics as assessed by the post-procedural questionnaire

    Measured: Perioperative

  3. Burnout

    Burnout as assessed by the Mini-Z survey. A higher score indicates increased burnout

    Measured: From enrollment to end of study period at 14 days

  4. Heart Rate

    Heart rate as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  5. Sleep

    Sleep metrics as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  6. Blood oxygen

    Blood oxygen as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  7. Respiratory rate

    Respiratory rate as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  8. Body temperature

    Body temperature as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  9. Workout metrics

    Workout metrics as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

  10. Energy consumption

    Energy consumption as assessed by the wearable device(s).

    Measured: From enrollment to end of study period at 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2026
  2. Study start4 Oct 2023
  3. Primary completion4 Oct 2027 (estimated)
  4. Study completion4 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07804927
Sponsor's protocol ID
STRAIN
Status last verified
Aug 2026
First submitted
17 Aug 2026
Last updated
4 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stress, run by Minneapolis Heart Institute Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart Rate Variability (HRV) (time frame: From enrollment to end of study period at 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in